Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Anna Veprik

Novo Nordisk Postdoctoral Research Fellow (2016-2019)

  • Project: Investigating lipid metabolism in islet a-cells and gut L-cells, as a nutrient sensing mechanism controlling hormone secretion


Anna was awarded the Novo Nordisk Postdoctoral Fellowship in 2016, working with Dr James Cantley and Professor Heidi de Wet in DPAG. During her fellowship, she broadened the understanding of the connection between nutritional status of the pancreatic α and gut enteroendocrine L-cells and their ability to respond to metabolic stimuli. This work combined the establishment of genetically and pharmacologically modified organisms, primary ex vivo models and cell lines. It uncovered the central role played by Acetyl-CoA-Carboxylase 1 (ACC1) in the regulation of endocrine cell growth and hormone secretion.

Following her fellowship, Anna joined the Novo Nordisk Research Centre Oxford (NNRCO) as a Post-Doctoral Research Scientist in the Department of Discovery Biology and Pharmacology. She has recently accepted a permanent position at NNRCO as a Senior Research Scientist. In her new role, Anna is pursuing further her long-standing interest in the multi-organ pathophysiology of metabolic diseases. She is leading the development of high-throughput screening platforms for unbiased target identification in the liver.